Conversation between researchers beside poster presentations

Seminar Series Schedule 2019

 

Department of Regenerative Medicine & Cell Biology

Date Presenter Title
11/13/19 Nancy DeMore, M.D. Development of a Humanized Monoclonal Antibody to Secreted Frizzled Related Protein 2 for Cancer
10/30/19 Eduardo Maldonado, Ph.D. TBA
10/23/19 Mythreye Karthikeyan, Ph.D. TBA
10/16/19 Seok-Hyung Kim, Ph.D.  TBA
10/09/19 Ann-Marie Broome, Ph.D. TBA
10/02/19 Denis Guttrige, Ph.D. NF-kB Involvement in Pancreatic Cancer
09/25/19 Anand Mehta, D.Phil. GlycoTest, GlycoPath, GlycoCure: Diagnosis, Prognosis, and Treatments for Hepatocellular Carcinoma
09/11/19 Alexander Alekseyenko, Ph.D. Microbiome Data Science and Informatics
05/15/19 Markus Grompe, M.D. In vivo selection for the enhancement of liver-targeted cell and gene therapy
05/08/19 Earnest Ramsay Camp, M.D., MSCR The role of patient-derived models for colorectal cancer precision medicine
05/01/19 Deepak Nihalani, Ph.D. Taming TGF-β signaling by a Non-conventional Motor Myo1c
04/10/19 Renee Cottle, Ph.D. Ex vivo Genome Editing as a Therapeutic Approach: Engineering the Delivery System and Lingering Challenges
03/27/19  Ann Foley, Ph.D. Kinase signaling in SAN differentiation
03/20/19 Satish Nadig, M.D., Ph.D., FACS Pretreatment Strategies in Organ Transplantation
02/13/19 Hang Yin, Ph.D. Ironing Out Oxidative Stress during Brown Adipose Thermogenesis
02/6/19 Bei Liu, M.D., MPH The Interplay Between Dendritic Cells and Microbiota in Gut Inflammation
01/23/19 Wenjian Gan, Ph.D., MUSC Targeting E3 Ubiquitin Ligases for Cancer Therapy
01/16/19 John O'Bryan, Ph.D., MUSC New Insights into RAS Signaling and Therapeutic Inhibition
01/09/19 Joe Delaney, Ph.D., Medical University of South Carolina Copy Number Alterations in Low Mutation Cancer
11/28/18 Bishr Omary, M.D., Ph.D., University of Michigan Porphyrin-triggered protein aggregation: mechanism and porphyria implications
11/7/18 Mary Sorci-Thomas, Ph.D., Medical College of Wisconsin SR-BI and PCPE2: novel partners in adipocyte lipid storage
10/31/18 Je-Hyun Yoon, Ph.D., MUSC Intestinal miRNAs in alcohol-induced tissue injury
10/24/18 Chad Novince, Ph.D., DDS, MUSC Commensal Microbiota Immunomodulatory Actions in Gut - Liver Critically Regulate Post-Pubertal Skeletal Development
10/17/18 Daria Ilatovskaya, Ph.D., MUSC RAAS-independent effects of Atrial Natriuretic Peptide in salt-sensitive hypertension
10/10/18 Teresa Ku, Ph.D., Institute of City of Hope Stem and progenitor likecells from adult pancreas for potential cell replacement therapy
9/26/18 Andrew Jakymiw, Ph.D., MUSC Design of peptide carriers for delivery of therapeutic small RNAs in the treatment of cancer
9/19/18 Dieter Haemmerich, Ph.D., MUSC Image-guided drug delivery
5/09/18 Andrew Ewald, Johns Hopkins Cellular and molecular mechanisms of liver metastasis
4/17/18 Nico Katsanis, Duke University The complexity of simple genetics
1/10/18 Jorge Munera, Cincinnati Children's Hospital Pluripotent stem cell derived human colonic organoids
11/29/17 Valeri Vasioukhin, Fred Hutchinson Cancer Center Cell-cell adhesion mechanisms in regulation of normal tissue homeostasis in GI cancer
8/23/17 Robert Schwartz, Weill Cornell University Modeling human liver disease using stem cells derived & primary cell platforms
2/22/17 Stephen Dalton, University of Georgia How human pluripotent stem cells can help us understand metabolism and metabolic disease
2/02/17 Junsu Kang, Duke University Fishing for regulators of tissue regeneration
                                                                                                  

Department of Medicine - Gastroenterology Grand Rounds

Date Presenter Title
10/10/18 Marwan Georgi, M.D., Catalyst Medical Consulting Large database analysis research in GI: The goldmine hidden in plain site
5/10/18 Christopher Goss, M.D., Seattle Children's Hospital Cystic fibrosis: A changing disease paradigm
3/22/18 C. Thomas Caskey, M.D., Baylor College of Medicine Precision medical diagnosis
1/11/18 Nicholas Davidson, M.D., Washington University Genetic testing in GI cancer: Hope or hype?
11/15/17 David Perlmutter, M.D., Washington University Drug discovery for alpha-1 antitrypsin disease
4/20/17 Stephen Meltzer, M.D., Johns Hopkins Early detection and prognostication of Barrett’s esophagus and esophageal cancer
4/13/17 Thomas Imperiale, M.D., Indiana University Screening for colorectal cancer
1/26/17 John Kuemmerle, M.D., Virginia Commonwealth Positioning current and future therapies for IBD